We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 5,305

Exchange rate for the pricing of Pharmaceuticals in Turkey for 2018
  • NSN Law Firm
  • Turkey
  • February 13 2018

Pursuant to the Decree Regarding Pricing of Pharmaceuticals dated February 6, 2017 ("Pricing Decree"), the annual exchange rate in relation to the


Patents: supplementary protection certificates
  • Bird & Bird
  • European Union
  • February 9 2018

The European Court of Justice (ECJ) has ruled that only a granted marketing authorisation could be used to apply for a supplementary protection


From 2020, Russia will introduce a compulsory system for tracking pharmaceuticals from manufacturer to end user
  • Dentons
  • Russia
  • February 9 2018

On December 29, 2017, the RF President signed Federal Law No. 425-FZ of December 28, 2017 On Amendments to the Federal Law On the Circulation of


The State AG Weekly Update February 8, 2018
  • Cozen O'Connor
  • USA
  • February 8 2018

North Dakota AG Wayne Stenehjem declared his intention to run for reelection to a sixth term in 2018. Prior to taking office as AG in 2000, AG Ste


Counterfeiting in the pharmaceutical industry
  • Spoor & Fisher
  • South Africa
  • February 6 2018

Pharmaceutical products (medicine) form an important and vital part of any country's healthcare system. Yet the presence of counterfeit


Pharmaceutical Bill Passed for Patent Linkage and Data Exclusivity on Novel Indications
  • Tsai Lee & Chen Patent Attorneys & Attorneys at Law
  • Taiwan
  • February 6 2018

At the end of 2017, Taiwan's Legislative Yuan passed a bill amending the Pharmaceutical Act. These amendments establish a patent linkage system and


Pharmaceutical Bill Passed for Patent Linkage and Data Exclusivity on Novel Indications1
  • Tsai Lee & Chen Patent Attorneys & Attorneys at Law
  • Taiwan
  • February 6 2018

News IP Court Pharmaceutical Bill Passed for Patent Linkage and Data Exclusivity on Novel Indications1 At the end of 2017, Taiwan’s Legislative Yuan


The Medicines Company v. Hospira, Inc.
  • Knobbe Martens
  • USA
  • February 6 2018

A distribution agreement qualifies as an invalidating “offer for sale” under 35 U.S.C. 102(b) when the terms of the agreement demonstrate the commercial character of an offer to sell the patented product


What Do You Mean Someone I've Never Met Is My Employee?
  • Vinson & Elkins LLP
  • USA
  • February 6 2018

While the current National Labor Relations Board appears to be heading in the right direction when it comes to the joint employer and independent


Life sciences & Healthcare in Ukraine - 2017 in Review
  • Kinstellar
  • Ukraine
  • February 2 2018

Establishment of the National Healthcare Service of Ukraine (the "Service"